Form D — Aegle Therapeutics Corp
0001797825-26-000007 · filed Aug 28, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $2,277,698
- Reported amount sold
- $2,277,698
- Minimum investment
- $0
- Investors
- 17
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Aegle Therapeutics Corp
- CIK
- 1797825
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 400 TRADECENTER
WOBURN, MA 01801 - Phone
- 781-918-8449
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Shelley Hartman · Executive OfficerWOBURN, MA Find on LinkedIn ↗
-
Scott Braunstein · DirectorWOBURN, MA Find on LinkedIn ↗
-
Leon Moulder · DirectorWOBURN, MA Find on LinkedIn ↗
-
Evangelos Badiavas · DirectorWOBURN, MA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗